SF
BLUE

Synovus Financial’s bluebird bio BLUE Stock Holding History

Synovus Financial’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1
Closed -$1K – 1617
2020
Q1 		$1K Buy
+1
New +$975 ﹤0.01% 2006
2018
Q3 		– Sell
-1
Closed -$2K – 1381
2018
Q2 		$2K Buy
+1
New +$2.28K ﹤0.01% 1192
2014
Q2 		– Sell
-154
Closed -$46K – 911
2014
Q1 		$46K Hold
154
– – ﹤0.01% 579
2013
Q4 		$42K Buy
+154
New +$43K ﹤0.01% 573

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Synovus Financial's BLUE Position: Q2 2020 in Review

Synovus Financial sold out of bluebird bio (BLUE) in Q2 2020, closing a stake of 1 share — an estimated $1K sold.

Synovus Financial first reported a position in BLUE in Q4 2013 and held it in 4 quarters. The position peaked at $46K in Q1 2014. 278 funds tracked by Wall St. Rank hold BLUE as of Q2 2020.

  • Synovus Financial reported no remaining bluebird bio position as of Q2 2020 after selling out during the quarter.
  • Synovus Financial sold 1 bluebird bio share in Q2 2020, an estimated $1K.
  • Synovus Financial first reported a position in bluebird bio in Q4 2013 and held it in 4 quarters.
  • Synovus Financial's bluebird bio position peaked at $46K in Q1 2014.
  • 278 funds tracked by Wall St. Rank held bluebird bio as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.